UA117173C2 - METHOD FOR CORRECTION OF IMMUNETMETABOLIC PROFILE IN ADULT PATIENTS WITH RECURRENT DEPRESSION DISORDERS - Google Patents

METHOD FOR CORRECTION OF IMMUNETMETABOLIC PROFILE IN ADULT PATIENTS WITH RECURRENT DEPRESSION DISORDERS

Info

Publication number
UA117173C2
UA117173C2 UAA201610198A UAA201610198A UA117173C2 UA 117173 C2 UA117173 C2 UA 117173C2 UA A201610198 A UAA201610198 A UA A201610198A UA A201610198 A UAA201610198 A UA A201610198A UA 117173 C2 UA117173 C2 UA 117173C2
Authority
UA
Ukraine
Prior art keywords
correction
profile
immunetmetabolic
adult patients
recurrent depression
Prior art date
Application number
UAA201610198A
Other languages
Ukrainian (uk)
Inventor
Ганна Михайлівна Кожина
Ірина Федорівна Тєрьошина
Original Assignee
Харківський Національний Медичний Університет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківський Національний Медичний Університет filed Critical Харківський Національний Медичний Університет
Priority to UAA201610198A priority Critical patent/UA117173C2/en
Publication of UA117173C2 publication Critical patent/UA117173C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Винахід належить до галузі медицини, а саме до психіатрії, та стосується способу корекції імунометаболічного профілю у дорослих, хворих на рекурентні депресивні розлади, що включає введення антидепресантів, реамберину, аміксину IС у средньотерапевтичних дозах, та додатково ентеросорбенту "Біле вугілля".The invention relates to medicine, namely to psychiatry, and relates to a method of correction of the immunometabolic profile in adults suffering from recurrent depressive disorders, including the introduction of antidepressants, reamberin, amixin IC in median therapeutic doses, and additionally "enterosor".

UAA201610198A 2016-10-07 2016-10-07 METHOD FOR CORRECTION OF IMMUNETMETABOLIC PROFILE IN ADULT PATIENTS WITH RECURRENT DEPRESSION DISORDERS UA117173C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201610198A UA117173C2 (en) 2016-10-07 2016-10-07 METHOD FOR CORRECTION OF IMMUNETMETABOLIC PROFILE IN ADULT PATIENTS WITH RECURRENT DEPRESSION DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201610198A UA117173C2 (en) 2016-10-07 2016-10-07 METHOD FOR CORRECTION OF IMMUNETMETABOLIC PROFILE IN ADULT PATIENTS WITH RECURRENT DEPRESSION DISORDERS

Publications (1)

Publication Number Publication Date
UA117173C2 true UA117173C2 (en) 2018-06-25

Family

ID=62781460

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201610198A UA117173C2 (en) 2016-10-07 2016-10-07 METHOD FOR CORRECTION OF IMMUNETMETABOLIC PROFILE IN ADULT PATIENTS WITH RECURRENT DEPRESSION DISORDERS

Country Status (1)

Country Link
UA (1) UA117173C2 (en)

Similar Documents

Publication Publication Date Title
MX2021000071A (en) Use of pridopidine to improve cognitive function and for treating alzheimer's disease.
PH12017502103A1 (en) Methods and kits for treating depression
EA201590654A1 (en) COMBINATION OF RASAGILIN AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF HANTINGTON'S DISEASE
EA201791199A1 (en) METHOD OF TREATMENT OF ALZHEIMER'S DISEASE
EA201590655A8 (en) COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
MX2019010994A (en) Methods for treating complement-mediated diseases and disorders.
EA201990424A1 (en) SPIRALACTAM MODULERS OF NMDA RECEPTOR AND THEIR APPLICATION
EA201990425A1 (en) SPIRO-LACTAM AND BIS-SPIRO-LACTAM MODULATORS OF THE NMDA RECEPTOR AND THEIR APPLICATION
EA201990428A1 (en) SPIRALACTAM MODULERS OF NMDA RECEPTOR AND THEIR APPLICATION
EA201590359A1 (en) TREATMENT OF RHEUMATOID ARTHRITIS
EA201892265A1 (en) METHODS OF TREATMENT OF OPHTHALMIC DISEASES
EA201691656A2 (en) THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
EA201691567A1 (en) METHODS OF TREATING PULMONARY INJURIES TO THE BRAIN
WO2016029136A8 (en) 3-amidobenzamides and uses thereof for increasing cellular levels of a3g
MX2022005813A (en) Novel dosage forms of rofecoxib and related methods.
CY1124492T1 (en) 7-Substituted 1-aryl-naphthyridine-3-carboxamides and their use
MX2020010119A (en) Anti-cd27 antibody, antigen-binding fragment thereof and medical use thereof.
MD20170025A2 (en) Medical treatments based on anamorelin
BR112018067554A2 (en) testosterone formulations and treatment methods with them
MX2022003134A (en) Intranasal administration of esketamine.
MX2019005309A (en) Anti-bag3 antibodies in combination with inhibitors of immune check-point for therapeutic use.
BR112021014566A2 (en) gpr35 modulators
Fiscalini The clinical analysis of transference
UA117173C2 (en) METHOD FOR CORRECTION OF IMMUNETMETABOLIC PROFILE IN ADULT PATIENTS WITH RECURRENT DEPRESSION DISORDERS
IL288636A (en) Dosage and administration regimen for the treatment or prevention of c5-related diseases by the use of the anti-c5 antibody crovalimab